1. Home
  2. ASTC vs TENX Comparison

ASTC vs TENX Comparison

Compare ASTC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$7.19

Market Cap

14.5M

Sector

Industrials

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$1.83

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTC
TENX
Founded
1984
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
71.1M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
ASTC
TENX
Price
$7.19
$1.83
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $29.67
AVG Volume (30 Days)
28.0K
★ 3.9M
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2600.00
N/A
EPS
★ 0.25
N/A
Revenue
★ $1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.72
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.92
$1.31
52 Week High
$68.85
$19.40

Technical Indicators

Market Signals
Indicator
ASTC
TENX
Relative Strength Index (RSI) 51.53 27.10
Support Level $6.80 $1.31
Resistance Level $7.71 $2.22
Average True Range (ATR) 0.51 0.12
MACD 0.14 0.32
Stochastic Oscillator 78.33 5.95

Price Performance

Historical Comparison
ASTC
TENX

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: